Institute for Cardiovascular Diseases of Vojvodina Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2019
NCT03832660
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Institute for Cardiovascular Diseases of Vojvodina